Entry |
|
Name |
Minzasolmin (USAN/INN) |
Formula |
C23H31N5OS
|
Exact mass |
425.2249
|
Mol weight |
425.59
|
Structure |

|
Efficacy |
Neurodegenerative diseases agent, alpha-Synuclein misfolding inhibitor |
Comment |
Treatment of Parkinson's disease
|
Target |
|
Pathway |
|
Brite |
Target-based classification of drugs [BR:br08310]
Not elsewhere classified
Cellular process
Membrane trafficking
SNCA
D12796 Minzasolmin (USAN/INN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 30
1 C1x C 8.2600 -15.0500
2 N1y N 8.2600 -16.4500
3 C1x C 9.4724 -17.1500
4 C1x C 10.6849 -16.4500
5 N1y N 10.6849 -15.0500
6 C1x C 9.4724 -14.3500
7 C1a C 7.0476 -17.1500
8 C8y C 11.9160 -14.3390
9 S2x S 13.2440 -14.7420
10 C8y C 14.0399 -13.6027
11 C8x C 13.2023 -12.4937
12 N5x N 11.8888 -12.9476
13 C5a C 15.4700 -13.5766
14 N1b N 16.1934 -14.7786
15 O5a O 16.1464 -12.3542
16 C1c C 17.5699 -14.7534
17 C1b C 18.2994 -15.9650
18 C8y C 19.6699 -15.9397
19 C1b C 18.2406 -13.5411
20 C8x C 20.5234 -17.0698
21 N4x N 21.8620 -16.6073
22 C8y C 21.8357 -15.1913
23 C8y C 20.4809 -14.7787
24 C8x C 22.8586 -14.2353
25 C8x C 22.5421 -12.8716
26 C8x C 21.1873 -12.4590
27 C8x C 20.1645 -13.4149
28 C1b C 17.5130 -12.3323
29 C1b C 18.2130 -11.1199
30 C1a C 17.5142 -9.9095
BOND 33
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 5 6 1
6 1 6 1
7 2 7 1
8 5 8 1
9 8 9 1
10 9 10 1
11 10 11 2
12 11 12 1
13 8 12 2
14 10 13 1
15 13 14 1
16 13 15 2
17 14 16 1
18 16 17 1
19 17 18 1
20 16 19 1 #Down
21 18 20 2
22 20 21 1
23 21 22 1
24 22 23 1
25 18 23 1
26 22 24 2
27 24 25 1
28 25 26 2
29 26 27 1
30 23 27 2
31 19 28 1
32 28 29 1
33 29 30 1
|